Amgen To Launch Study On PCSK9 Inhibitors Use On Cardiovascular Issues

Data : 15/11/2019 @ 18:42
Fonte : Alliance News
Titolo : Amgen Inc (0R0T)
Quotazione : 218.875  0.0 (0.00%) @ 17:06
Quotazione Amgen Grafico

Amgen To Launch Study On PCSK9 Inhibitors Use On Cardiovascular Issues

Inc on Friday announced plans to launch a study into the use of PCSK9 inhibitors on cardiovascular outcomes in clinical practice. PCSK9...
Subscribe now to see this Premium News article from
Alliance News Professional covers every UK stock in your portfolio. It goes beyond regulatory news and free web services to give your investment decisions an edge over the crowd.
  • In The Know - Management and analyst comments that go beyond company announcements.
  • Flash headlines on all 2,400 London-listed companies before the news hits the open web.
  • Broker Ratings - The earliest tip-offs, many before the market opens.
  • Economic data and central bank flashes from UK, US and eurozone.
  • Taking AIM - Up to the minute market commentary on AIM stocks.
  • Over 500 news items per trading day for just £39.60 per month, and cancel at any time.
Call us on +44 (0) 203 8794 460 to get started.

Grafico Azioni Amgen (LSE:0R0T)
Storico


Da Giu 2019 a Giu 2020

Clicca qui per i Grafici di Amgen

Grafico Azioni Amgen (LSE:0R0T)
Intraday


Giovedì 4 Giugno 2020

Clicca qui per i Grafici di Amgen
La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20200604 15:21:34